Last updated:
Brian Johnson said his health may have been more negatively affected by rapamycin use than positively.
Anti-aging influencer and tech entrepreneur Brian Johnson has stopped taking the medication that helped him live longer. The 47-year-old billionaire shot to fame for his efforts to turn back the clock on biological age. Johnson had been taking 13 milligrams of the immunosuppressant drug rapamycin for the past five years in order to live “forever.” However, he discovered that its modest benefits were outweighed by its negative side effects and has now stopped taking it.
Transplant patients usually take rapamycin to prevent organ rejection. Johnson, who implemented “the most aggressive rapamycin protocol in the industry,” said the drug may have done more harm than good.
“On September 28, I decided to discontinue rapamycin, ending nearly five years of experimentation with this molecule for its longevity potential,” Johnson said. Johnson is featured in a new Netflix documentary, “Don’t Die: The Don’t Die.” A man who wants to live forever. ”
“Despite the tremendous potential provided by preclinical studies, my team and I have concluded that the benefits of lifelong rapamycin do not justify the significant side effects,” Johnson said. he added.
According to the former Silicon Valley CEO, preclinical and clinical studies have shown that long-term use of rapamycin can cause insulin and glucose intolerance and affect lipid metabolism. According to the New York Post, Johnson stopped taking rapamycin after filming the documentary, admitting that it may have had the opposite effect than intended.
Johnson spends $2 million a year on medical tests and treatments, along with a carefully planned diet, sleep schedule and exercise routine, to halt, if not reverse, the aging process.
Johnson reportedly revealed that he underwent a complete plasmapheresis several months ago, in which pure albumin (a protein present in human blood plasma) is used to replace fluids in the body. ) was used. He stressed that this procedure was different from when he exchanged blood with his adolescent son, whom he bizarrely called “Blood Boy” in 2023.
Brian Johnson is known for founding Braintree, a mobile and web payment solution for e-commerce companies, which was later acquired by PayPal. After selling his company, Johnson is now focusing on anti-aging efforts. He is also the founder of the neurotechnology company Kernel, which manufactures helmets specifically designed to measure brain activity.